Extendicare Inc. (TSE:EXE – Free Report) – Leede Financial lifted their FY2024 earnings estimates for Extendicare in a report issued on Wednesday, November 13th. Leede Financial analyst D. Loe now forecasts that the company will earn $1.03 per share for the year, up from their previous estimate of $0.89. The consensus estimate for Extendicare’s current full-year earnings is $0.61 per share. Leede Financial also issued estimates for Extendicare’s FY2027 earnings at $1.49 EPS.
Several other analysts have also recently issued reports on EXE. Royal Bank of Canada increased their price objective on Extendicare from C$8.50 to C$9.50 in a research note on Monday, August 19th. TD Securities increased their price target on Extendicare from C$9.50 to C$10.50 and gave the company a “hold” rating in a research report on Thursday.
Extendicare Trading Up 1.3 %
Shares of EXE stock opened at C$10.14 on Friday. The company has a 50 day moving average price of C$9.27 and a 200 day moving average price of C$8.15. The stock has a market capitalization of C$846.39 million, a P/E ratio of 14.91 and a beta of 1.26. The company has a debt-to-equity ratio of 305.80, a quick ratio of 0.98 and a current ratio of 0.60. Extendicare has a fifty-two week low of C$6.41 and a fifty-two week high of C$10.43.
Extendicare Dividend Announcement
The firm also recently announced a monthly dividend, which was paid on Friday, November 15th. Stockholders of record on Thursday, October 31st were issued a $0.04 dividend. The ex-dividend date was Thursday, October 31st. This represents a $0.48 dividend on an annualized basis and a dividend yield of 4.73%. Extendicare’s payout ratio is 70.59%.
About Extendicare
Extendicare Inc, through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties.
Read More
- Five stocks we like better than Extendicare
- What is a Dividend King?
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- Canada Bond Market Holiday: How to Invest and Trade
- Top-Performing Non-Leveraged ETFs This Year
- How to Invest in Blue Chip Stocks
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
